Fluorescence immunochip assay for thyroid stimulating hormone in whole blood

BioChip Journal - Tập 7 - Trang 408-414 - 2013
Jeong Hyeok Jeong1, Tae Kyum Kim1,2, Sang Wook Oh3, Eui Yul Choi1,2
1Boditech Med Inc., Chuncheon, Korea
2Department of Biomedical Science, Hallym University, Chuncheon, Korea
3Department of Biology Education, Institute of Fusion Science, Chonbuk National University, Jeonju, Korea

Tóm tắt

The determination of blood level of thyroid stimulating hormone (TSH) is an important biomarker for the clinical assessment of thyroid status. Here, we presented a new fluorescence (FL) immunochip TSH assay system, which was developed with a platform of point-of-care test (POCT) for clinical applications. The assay system adopted a lateral-flow immunochromatographic technology and consisted of anti-TSH-mAb coated strip in a disposable chip, a detection buffer containing FL-labeled anti-TSH-pAb, a calibration chip, and a laser FL scanner. The analytical performance of FL immunochip TSH assay system was evaluated by linearity, interference, recovery, and imprecision tests. The comparability of the developed assay was examined with an automated reference assay. The developed assay system exhibited an excellent linearity in working range of 1–100 μIU/mL and was affected neither a large amount of various serum interference substances nor similar structure biomolecules to TSH. The analytical mean recovery of control was 97.6% in a dynamic working range and the imprecision of intra- and inter-assay of CVs was less than 10%. There was a significant correlation between the developed TSH assay and the Beckman Coulter Access 2 TSH assay (r=0.989, p<0.001). The developed FL immunochip assay is the only method that quantifies TSH concentration in whole blood and meets the criteria of POCT including affordable cost, a disposable device, and requiring minimum maintenance to perform test.

Tài liệu tham khảo

Cohen, K.L. Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review. Metabolism 26, 1165–1177 (1977). Pierce, J.G. Eli Lilly lecture. The subunits of pituitary thyrotropin-their relationship to other glycoprotein hormones. Endocrinology 89, 1331–1344 (1971). Dwyer, J.M. Transfer factor in the age of molecular biology: a review. Biotherapy 9, 7–11 (1996). Jeffcoate, S.L. The control of testicular function in the adult. Clin. Endocrinol. Meta. 3, 521–543 (1975). Tarim, O. Thyroid hormones and growth in health and disease. J. Clin. Res. Pediatr. Endocrinol. 3, 51–55 (2011). Lundy, L.E. et al. The ovulatory cycle. A histologic, thermal, steroid, and gonadotropin correlation. Obstet. Gyneco. 44, 14–25 (1974). Filers, E. et al. Hypothalamic thyroid hormone feedback in health and disease. Prog. Brain. Res. 153, 189–207 (2006). Marshal, J.C. Clinics in endocrinology and metabolism. Investigative procedures. J. Clin Endocrinol. Metab. 3, 545–567 (1975). Burger, H.G. & Patel, Y.C. Thyrotropin releasing hormone-TSH. J. Clinic. Endocrinol. Metab. 6, 83–100 (1977). Paterson, N. et al. Evaluation of a time-resolved immunofluorometric assay for serum thyroid stimulating hormone. Ann. Clin. Biochem. 22, 606–611 (1985). Suonpaa, M. et al. Europium-labelled streptavidin as a highly sensitive universal label. Indirect time-resolved immunofluorometry of FSH and TSH. J. Immunol. Methods. 2, 247–253 (1992). Squire, C.R. & Gimlette, T.M. Assessment of an enhanced chemiluminescent immunometric assay for TSH in 1127 patients. Ann. Clin. Biochem. 24, 419–425 (1987). Von Lode, P. et al. One-step quantitative thyrotropin assay for the detection of hypothyroidism in point-ofcare conditions. Clin. Biochem. 2, 121–128 (2003). Helfand M. & Redfern C. Clinical guideline, part 2. Screening for thyroid disease: An update. Ann. Intern. Med. 129, 144–158 (1998). Baloch, Z. et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3–126 (2003). Pop, V.J. et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. 50, 149–155 (1999). Rawlins, M.L. & Roberts, W.L. Performance characteristics of six third-generation assays for thyroidstimulating hormone. Clin. Chem. 50, 2338–2344 (2004). Serdar, M.A. et al. Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer. Clin. Chem. Lab. Med. 50, 1849–1852 (2012). Zhang, B. et al. Nanogold-functionalized magnetic beads with redox activity for sensitive electrochemical immunoassay of thyroid-stimulating hormone. Anal. Chim. Acta. 711, 17–23 (2012). Kim, B.C. et al. Simplified laser fluorescence scanner for proteomics studies and early cancer diagnosis. Proc. SPIE 4916, 103–108 (2002).